Corporate Ethos

Corporate Ethos

At Vilin Bio Med, we are committed to upholding the highest standards of corporate governance, ethical business practices, and regulatory compliance. As a publicly listed company, we adhere to all applicable regulations and guidelines issued by governing bodies such as SEBI, MCA, RBI, CCI, CBDT, CBIC, CDSCO, NPPA, GMP, PCI, and DPCO to ensure that we maintain transparency, integrity, and accountability in every aspect of our operations.

Compliance with Regulatory Frameworks

Securities and Exchange Board of India (SEBI)
  • Listing and Disclosure Compliance: We strictly follow the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. All financial and non-financial disclosures are made transparently, including timely quarterly and annual reports, material events, related-party transactions, and governance updates. Insider Trading Compliance: We adhere to SEBI’s Prohibition of Insider Trading Regulations, ensuring that all employees, directors, and stakeholders are prohibited from using any unpublished price-sensitive information (UPSI) for trading. Investor Protection: We uphold transparency in investor relations by providing timely and accurate information, answering investor queries, and ensuring that all investor rights are respected.
Ministry of Corporate Affairs (MCA)
  • Corporate Governance: We comply with the Companies Act, 2013 to maintain a transparent, accountable, and ethical corporate governance framework. Our Board of Directors and its Committees adhere to governance best practices as laid down by MCA. Annual Filings: We ensure timely filing of all regulatory documents, including Annual Return (Form MGT-7), Financial Statements (Form AOC-4), and Director’s Report in accordance with MCA guidelines.
  • Corporate Social Responsibility (CSR): We invest a significant portion of our profits in CSR activities aimed at health, education, environment, and community welfare, as mandated by the Companies (CSR Policy) Rules.
Reserve Bank of India (RBI)
  • Financial Compliance: We follow RBI regulations on foreign exchange management, financial operations, and liquidity requirements, especially concerning external commercial borrowings (ECBs) and foreign investments.
  • Risk Management: We implement RBI’s risk management framework to manage operational and financial risks and ensure the integrity of our financial systems.
  • Monetary Policy Compliance: Our financial operations comply with RBI’s monetary policy, ensuring effective management of capital, liquidity, and exchange rate risks.
Competition Commission of India (CCI)
  • Fair Market Practices: We comply with the Competition Act, 2002 to avoid anti-competitive behavior, market manipulation, and abuse of dominance. We maintain fair trade practices and avoid restrictive trade agreements.
  • Mergers and Acquisitions: In case of any merger, acquisition, or restructuring, we ensure compliance with CCI guidelines to prevent anti-competitive impacts and preserve market competition.
  • Promoting Innovation: We encourage market-driven competition and innovation in our products and services, which ultimately benefits consumers.
Central Board of Direct Taxes (CBDT)
  • Tax Compliance: We comply with CBDT’s guidelines regarding income tax and advance tax payments, filing of tax returns, and tax audits in line with the Income Tax Act, 1961.
  • Transfer Pricing: We follow transfer pricing regulations for inter-company transactions, ensuring fair pricing in line with market rates.
  • Tax Planning: We adopt tax-efficient strategies while ensuring full compliance with the CBDT provisions to optimize the company’s tax liability.
Central Board of Indirect Taxes and Customs (CBIC)
  • GST Compliance: We adhere to all provisions of the Goods and Services Tax Act (GST), ensuring timely filing of GST returns, accurate tax payments, and compliance with GST audits.
  • Customs and Excise: We comply with customs duties and excise regulations as per CBIC guidelines, ensuring proper valuation and documentation in the import and export of goods.
  • Indirect Taxation: We maintain compliance with all indirect tax regulations, ensuring transparency and accountability in tax reporting.

Compliance with Pharmaceutical and Healthcare Regulations

Central Drugs Standard Control Organization (CDSCO)
  • Regulatory Approvals: We comply with CDSCO regulations concerning the manufacturing, import, and distribution of pharmaceutical products, ensuring that all products meet safety, efficacy, and quality standards.
  • Good Manufacturing Practices (GMP): We adhere to GMP guidelines for manufacturing practices and processes, ensuring that all our pharmaceutical products meet the highest standards of quality, safety, and efficacy.
  • Licensing and Inspections: Our manufacturing facilities are regularly inspected by CDSCO to ensure compliance with licensing, production, and safety standards. National Pharmaceutical Pricing Authority (NPPA)
  • Price Control Regulations: We ensure compliance with NPPA guidelines, including the adherence to maximum retail prices (MRPs) for scheduled drugs as per the Drugs (Price Control) Order (DPCO).
  • Transparency in Pricing: We maintain transparency in the pricing of all pharmaceutical products and services, ensuring fairness and compliance with price control regulations. Good Manufacturing Practices (GMP)
  • Quality Assurance: Our manufacturing facilities are certified under Good Manufacturing Practices (GMP), ensuring that our products meet international standards for production, quality control, and safety.
  • Continuous Improvement: We follow a continuous improvement process to monitor and enhance the quality and compliance of our manufacturing practices. Pharmacy Council of India (PCI)
  • Compliance with PCI Standards: We ensure that our operations, especially those related to pharmaceutical sales, distribution, and marketing, are compliant with the standards set by the Pharmacy Council of India (PCI).
  • Training and Development: We provide regular training to our pharmacists and other key personnel to ensure compliance with PCI guidelines and promote the highest standards of professional conduct.
Drugs (Price Control) Order (DPCO)
  • Adherence to Price Controls: As a responsible healthcare provider, we strictly comply with the DPCO regulations that govern the pricing of essential drugs and their accessibility to the public.
  • Reporting and Transparency: We maintain transparent records of pricing, ensuring that our products are sold at fair prices and in compliance with government-mandated price controls.
Ethical Business Practices and Corporate Governance
  • Code of Conduct: We uphold the Code of Conduct in all our business dealings, ensuring integrity, fairness, and transparency at all levels.
  • Anti-Corruption and Anti-Bribery Policies: We have implemented a zero-tolerance policy towards corruption and bribery, ensuring compliance with all applicable anti-corruption laws and guidelines.
  • Conflict of Interest: Our directors and employees disclose any potential conflicts of interest and ensure that all decisions are made in the best interest of the company and its stakeholders.
Financial Transparency and Accountability
  • Timely and Accurate Reporting: We ensure that our financial reporting complies with Indian Accounting Standards (Ind AS) and is done in a timely and accurate manner, including quarterly and annual reports that are filed with the Stock Exchanges and the MCA.
  • Audit and Internal Controls: We maintain a robust internal control system and undergo regular external audits to ensure the integrity of our financial statements and regulatory compliance.
Sustainability and Corporate Social Responsibility
  • Sustainable Practices: We focus on sustainable and eco-friendly manufacturing processes, minimizing our environmental impact through efficient waste management, energy use, and eco-conscious product design.
  • CSR Initiatives: We actively participate in CSR activities, focusing on healthcare, education, community development, and environmental sustainability, in line with the Companies Act, 2013 and CSR Rules.
Risk Management
  • Comprehensive Risk Framework: We implement a comprehensive risk management framework to identify, assess, and mitigate risks related to market fluctuations, regulatory changes, operational disruptions, and financial volatility.
  • Crisis Management: We have established procedures to deal with any potential crises, ensuring minimal disruption to operations and compliance with regulatory requirements.
Stakeholder Engagement
  • Investor Communication: We ensure continuous and transparent communication with investors, providing regular updates and responding promptly to queries. Our Investor Relations Team is available to support investor needs and concerns.
  • Employee Engagement: We engage our employees through ongoing training, clear communication, and a positive work culture, ensuring that they understand and comply with regulatory standards and ethical business practices.

Conclusion

At Vilin Bio Med, our commitment to regulatory compliance, quality, and ethical conduct forms the foundation of our business. We strive to continuously improve our practices in line with the highest standards of governance and regulatory requirements from SEBI, MCA, RBI, CCI, CBDT, CBIC, CDSCO, NPPA, GMP, PCI, and DPCO. By adhering to these practices, we aim to foster trust with our stakeholders, contribute to the healthcare sector responsibly, and ensure sustainable growth and profitability for years to come.